Comparison of the effect of single and twice daily administration of ranitidine in relief of morning abdominal pain and nausea in childre
Phase 2
- Conditions
- abdominal pain and nausea.Unspecified abdominal pain
- Registration Number
- IRCT20171211037830N2
- Lead Sponsor
- Deputy of Research of Golestan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
abdominal pain and nausea
Exclusion Criteria
Nausea caused by extra-digestive system causes
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in abdominal pain. Timepoint: Two weeks and four weeks after starting treatment. Method of measurement: Question from parents.;Improvement in nausea. Timepoint: Question from parents. Method of measurement: improvement in nausea.
- Secondary Outcome Measures
Name Time Method